Richard Manning Email and Phone Number

Expert witness on intellectual property, damages, antitrust and other economic issues in Biopharmaceuticals, healthcare, and animal health.

Example Experiences:- In Wells Fargo Bank et al. v. Merrimack Pharmaceuticals, Inc., testified on behalf of plaintiffs who alleged that the company’s asset sale was a fundamental change, requiring the repurchase of convertible notes. Provided valuation of Merrimack’s pipeline of oncology drugs and opined that the sale of Merrimack’s sole commercial product constituted a fundamental change of the company. The parties settled.- In Pharmaceutical Solutions, Inc. (VetSource) v. Nevada State Board of Pharmacy et al., testified on behalf of VetSource, which sued in federal court in response to a cease and desist action that alleged illegal kickbacks. Evaluated the market for pet medications in Nevada and the VetSource business model to assess whether the company competes with other retail pharmacies in this market. The parties settled the federal lawsuit on undisclosed terms. Vetsource continues to operate in the state under its previously existing business model, and the complaint was rescinded. - Conducted detailed economic analysis on behalf of a global pharmaceutical company in connection with its $5.4 billion acquisition of an Animal Health company. The FTC approved the merger after an eight month investigation, with divestiture required in one product area, canine parasiticides.- Served as consulting expert to provide liability and damages analysis for a multinational pharmaceutical company in a qui tam case involving potential violations of state law in its marketing practices.

Directed economic analysis and strategy relative to the challenges affecting pricing and reimbursement, technology transfer to emerging markets, health technology assessment, health system evolution, intellectual property protection, and others arising in worldwide markets.

Strategy consulting in health care and pharmaceutical industry, including focus on strategic partnerships, deal activity and empirical economic analysis.

Academic research in economics of industrial organization and public policy; teching price theory, law and economics, regulatory economics, industrial organization.

Visiting professorship in Stigler Center for the Study of the Economy and the State.